Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
Roche - Doing now what patients need next
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
This website is hosted with Hoffmann LaRoche, Inc., which reserves the following IP addresses for researchcancerimmunotherapy.com: 198.21.19.135. Moreover, DNS used with this website include a1-178.akam.net, a18-66.akam.net, a4-67.akam.net, a6-65.akam.net, a7-66.akam.net, a9-66.akam.net. Subnet identifier ranges from 198.21.16.0 to 198.21.31.255. Classless Inter-Domain Routing (CIDR) is 198.21.16.0/20. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
a1-178.akam.net
a18-66.akam.net
a4-67.akam.net
a6-65.akam.net
a7-66.akam.net
a9-66.akam.net
{{value}}
2013-05-28
2024-05-28
Safenames Ltd.
{{value}}
The registrar of researchcancerimmunotherapy.com is Safenames Ltd. and the name expires on 2024-05-28. According to open source data, you can reach the owner at hostmaster@safenames.net but please make sure you have a good reason for unsolicited messages. Their country of residence is UK.
N/A
N/A
N/A
N/A
5K
34.1K
N/A
N/A
N/A
N/A